Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Interferon Signaling Is Frequently Downregulated in Melanoma.
Alavi S, Stewart AJ, Kefford RF, Lim SY, Shklovskaya E, Rizos H. Alavi S, et al. Among authors: shklovskaya e. Front Immunol. 2018 Jun 21;9:1414. doi: 10.3389/fimmu.2018.01414. eCollection 2018. Front Immunol. 2018. PMID: 29977240 Free PMC article.
Transcriptional downregulation of MHC class I and melanoma de- differentiation in resistance to PD-1 inhibition.
Lee JH, Shklovskaya E, Lim SY, Carlino MS, Menzies AM, Stewart A, Pedersen B, Irvine M, Alavi S, Yang JYH, Strbenac D, Saw RPM, Thompson JF, Wilmott JS, Scolyer RA, Long GV, Kefford RF, Rizos H. Lee JH, et al. Among authors: shklovskaya e. Nat Commun. 2020 Apr 20;11(1):1897. doi: 10.1038/s41467-020-15726-7. Nat Commun. 2020. PMID: 32312968 Free PMC article.
Tumor MHC Expression Guides First-Line Immunotherapy Selection in Melanoma.
Shklovskaya E, Lee JH, Lim SY, Stewart A, Pedersen B, Ferguson P, Saw RP, Thompson JF, Shivalingam B, Carlino MS, Scolyer RA, Menzies AM, Long GV, Kefford RF, Rizos H. Shklovskaya E, et al. Cancers (Basel). 2020 Nov 14;12(11):3374. doi: 10.3390/cancers12113374. Cancers (Basel). 2020. PMID: 33202676 Free PMC article.
Pathological response and tumour bed histopathological features correlate with survival following neoadjuvant immunotherapy in stage III melanoma.
Rawson RV, Adhikari C, Bierman C, Lo SN, Shklovskaya E, Rozeman EA, Menzies AM, van Akkooi ACJ, Shannon KF, Gonzalez M, Guminski AD, Tetzlaff MT, Stretch JR, Eriksson H, van Thienen JV, Wouters MW, Haanen JBAG, Klop WMC, Zuur CL, van Houdt WJ, Nieweg OE, Ch'ng S, Rizos H, Saw RPM, Spillane AJ, Wilmott JS, Blank CU, Long GV, van de Wiel BA, Scolyer RA. Rawson RV, et al. Among authors: shklovskaya e. Ann Oncol. 2021 Jun;32(6):766-777. doi: 10.1016/j.annonc.2021.03.006. Epub 2021 Mar 17. Ann Oncol. 2021. PMID: 33744385 Free article. Clinical Trial.
Melanoma Cell State-Specific Responses to TNFα.
Lim SY, Alavi S, Ming Z, Shklovskaya E, Fung C, Stewart A, Rizos H. Lim SY, et al. Among authors: shklovskaya e. Biomedicines. 2021 May 26;9(6):605. doi: 10.3390/biomedicines9060605. Biomedicines. 2021. PMID: 34073253 Free PMC article.
IFN-γ Signaling Sensitizes Melanoma Cells to BH3 Mimetics.
Ming Z, Lim SY, Stewart A, Pedersen B, Shklovskaya E, Menzies AM, Carlino MS, Kefford RF, Lee JH, Scolyer RA, Long GV, Rizos H. Ming Z, et al. Among authors: shklovskaya e. J Invest Dermatol. 2023 Jul;143(7):1246-1256.e8. doi: 10.1016/j.jid.2023.01.017. Epub 2023 Feb 1. J Invest Dermatol. 2023. PMID: 36736995
Intratumoral CD16+ Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy.
Lee H, Ferguson AL, Quek C, Vergara IA, Pires daSilva I, Allen R, Gide TN, Conway JW, Koufariotis LT, Hayward NK, Waddell N, Carlino MS, Menzies AM, Saw RPM, Shklovskaya E, Rizos H, Lo S, Scolyer RA, Long GV, Palendira U, Wilmott JS. Lee H, et al. Among authors: shklovskaya e. Clin Cancer Res. 2023 Jul 5;29(13):2513-2524. doi: 10.1158/1078-0432.CCR-22-2657. Clin Cancer Res. 2023. PMID: 36790412
34 results